Cardiovascular Disease Risk Factors Prevalence Among Bayer's Employees in São Paulo, Brazil

Bayer

Status: Completed

Conditions: Occupational Health

Treatments: Behavioral: Examination and survey

Study type: Observational

Funder types: Industry

Identifiers

NCT02055651

17312

NN1325BR (Other Identifier)

Details and patient eligibility

About

Introduction: As employees spent most part of their time at the worksite, it provides a venue to address multiple individual risk factors and promote health. The America Heart Association (AHA) defined cardiovascular health using as metrics smoking status, body mass index, physical activity, diet, total cholesterol, blood pressure and fasting blood glucose.

Objective: Evaluate Bayer employees' cardiovascular health according to the AHA definition and the acceptance to engage in lifestyle change programs.

Methods: By the time of the annual occupational safety periodic medical examination, employees will receive an email with information about the cardiovascular health screening, exams requisition (fasting blood glucose and total cholesterol) and a copy of the written informed consent. If the employee accepts to participate, after providing a written informed consent, he will be evaluated according to the AHA cardiovascular health metrics. Data will be collected at the occupational safety electronic health record. After medical evaluation, employees will receive a printed feedback with their cardiovascular health score and will be referred to indicated lifestyle change programs (healthy weight, smoking cessation, diabetes control, high blood pressure control, dyslipidemia control).

After 12 months we will evaluate the percentage of employees who accept to participate; prevalence of the cardiovascular risk factors and distribution according to the AHA classification in ideal, intermediate and poor; adherence to lifestyle change programs.

Enrollment: 361 patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Employees with 20 years of age or more that daily work at Bayer's site in São Paulo
• Provide written informed consent

Exclusion criteria

• Employees that will no longer work for Bayer in 30 days
• Employees that are retired from work during the study period

Trial design

361 participants in 1 patient group

Bayer Sao Paulo employees

Description:

Workers from Bayer in site Socorro who participate in the trial

Treatment:

Behavioral: Examination and survey